Date: 9.7.2018
Summary:
A German university has developed a marker for non-invasive diagnosis and differentiation of benign and malignant renal carcinoma. An unequivocal differentiation will improve the planning of the adequate treatment. The university offers a license agreement.
Reference: TODE20180309001
Country: Germany
Submitted: 9. 7. 2018
Keywords
Technology: Cytology, Cancerology, Oncology; Diagnostics, Diagnosis
Market: Differential diagnosis, Oncology
NACE: Other research and experimental development on natural sciences and engineering
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
ScienceWeek - Biotechnology Science since 1997
Science Magazine
New possibilities for the medical use of botulinun toxin A1
Traces of DNA in the stomachs of predatory snails provide new insights into the ecology of placozoans